Specialty Pharmacy

Top news of the day from across the healthcare landscape.

Approximately 300,000 pharmacists are eligible to vaccinate adult patients in the pharmacy.

The most impactful of the FDA designations, this status may be applied to drugs used to treat serious or life-threatening conditions.

FDA grants nivolumab (Opdivo) its seventh priority review designation.

Approximately 10% of the HIV population will die from lung cancer.

Patients undergoing chemotherapy can use Emend with other antiemetic medicines to prevent chemotherapy-related nausea and vomiting.

Patients with cancer were less likely to receive standard drugs and interventions for heart attack than patients without cancer.

Top news of the day from across the healthcare landscape.

Individuals with an undetectable HIV viral load are at effectively no risk of transmitting the virus.

Independent community pharmacies expand the services they offer patients.

Leaders in specialty pharmacy must work to improve employee engagement in order to boost the customer experience.

Many patients with rheumatoid arthritis feel their employers do not understand their condition.

Joel Wright, chief executive officer, Alliance Rx Walgreens Prime discusses challenges associated with combining specialty pharmacy operations.

Patients with hepatitis C virus achieve treatment success with specialists, primary care physicians, and nurse practitioners.

Top news of the day from across the healthcare landscape.

Ustekinumab (Stelara) treats moderate to severe plaque psoriasis in adolescents who are candidates for phototherapy or systemic therapy.

A look at last week's top stories in the world of pharmacy.

Novel discovery could lead to targeted cancer therapies.

Targeting RNA methylation could treat acute myeloid leukemia.

Marc O’Connor, chief operating officer at Curant Health, highlights upcoming trends to pay attention to within the specialty pharmacy landscape.

Top news of the day from across the healthcare landscape.

The lack of association of SVR with ribavirin dose reflects the wide variance in plasma levels between individuals with hepatitis C receiving the same weight-based dosage.

Top news of the week from Specialty Pharmacy Times.

Secretary of Labor to consider expanding access to Association Health Plans, which could allow employers to form groups across state lines.

Abemaciclib (Verzenio) may not improve overall survival in patients with non-small lung cancer.

Afatinib (Gilotrif) may treat patients with non-small cell lung cancer who have certain mutations.

Drinking coffee may have more profound survival benefits for patients with HIV and hepatitis C than for the general population.

Top news of the day from across the healthcare landscape.